Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New human SARS-CoV-2 vaccines based on AAV vectors presented

Oct. 26, 2021

Monash University divulges antibiotic peptide-drug conjugates

Oct. 25, 2021

Ligand grants CRDC Asian rights to develop COVID-19 antiviral using BEPro technology

Oct. 22, 2021

Dongguan Hec New Drug Research and Development synthesizes new HBV antivirals

Oct. 21, 2021

EDP-235 demonstrates potent antiviral activity against SARS-CoV-2 in cellular models

Oct. 20, 2021

Debiopharm awarded further funding to target N. gonorrhoeae

Oct. 20, 2021

CRyPTIC project identifies mutations conferring resistance to tuberculosis treatments

Oct. 20, 2021

Enesi and NIAID enter agreement to study ImplaVax-enabled pandemic flu vaccine

Oct. 19, 2021

Hygromycin A clears B. burgdorferi infection in mice

Oct. 19, 2021

Janssen BioPharma presents new influenza endonuclease inhibitors

Oct. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...